Ritesh Chimoriya, Sophie James, Leonard Kritharides, Shaundeep Sen, Samim Behdasht, Avinash Suryawanshi, Huw Davie, Janani Thillainadesan, Nadine Elias, Sarah Joy Aitken
{"title":"Recruitment Feasibility of Patients with Peripheral Artery Disease for a Multidisciplinary Intervention: Findings from the TEAM-PAD Trial.","authors":"Ritesh Chimoriya, Sophie James, Leonard Kritharides, Shaundeep Sen, Samim Behdasht, Avinash Suryawanshi, Huw Davie, Janani Thillainadesan, Nadine Elias, Sarah Joy Aitken","doi":"10.1016/j.avsg.2025.05.011","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Peripheral Arterial Disease (PAD) is a chronic progressive vascular condition with high morbidity and mortality, often necessitating comprehensive management to mitigate cardiovascular risk.</p><p><strong>Aims: </strong>This study assessed the feasibility of recruiting patients with PAD for a multidisciplinary team (MDT)-based care intervention, comparing its effectiveness to standard care within a clinical trial setting.</p><p><strong>Methods: </strong>Conducted as a cross-sectional analysis nested within the ongoing TEAM-PAD trial, this study targeted the recruitment of 30 patients within 12 weeks and evaluated recruitment, consent, and retention rates to assess feasibility.</p><p><strong>Results: </strong>A total of 30 participants were consented within 11 weeks, with an overall recruitment rate of 36.4% and retention rate of 90%. Baseline characteristics were balanced between groups. Participants had a mean age of 68.9 years and a high prevalence of comorbidities. The mean 10-year cardiovascular risk (SMART-REACH) was 42.8%. In the intervention group, implementing MDT recommendations is projected to reduce this risk by 12.1%.</p><p><strong>Conclusion: </strong>Recruitment of patients with PAD into an MDT intervention was feasible and timely, with strong retention and well-balanced baseline characteristics. While modelled estimates suggest a potential benefit from MDT recommendations, these findings are preliminary and based on a small interim cohort. Evaluation of clinical effectiveness within the larger ongoing randomised controlled trial is needed to evaluate the medium and long-term impacts of integrated vascular care.</p>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of vascular surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.avsg.2025.05.011","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Peripheral Arterial Disease (PAD) is a chronic progressive vascular condition with high morbidity and mortality, often necessitating comprehensive management to mitigate cardiovascular risk.
Aims: This study assessed the feasibility of recruiting patients with PAD for a multidisciplinary team (MDT)-based care intervention, comparing its effectiveness to standard care within a clinical trial setting.
Methods: Conducted as a cross-sectional analysis nested within the ongoing TEAM-PAD trial, this study targeted the recruitment of 30 patients within 12 weeks and evaluated recruitment, consent, and retention rates to assess feasibility.
Results: A total of 30 participants were consented within 11 weeks, with an overall recruitment rate of 36.4% and retention rate of 90%. Baseline characteristics were balanced between groups. Participants had a mean age of 68.9 years and a high prevalence of comorbidities. The mean 10-year cardiovascular risk (SMART-REACH) was 42.8%. In the intervention group, implementing MDT recommendations is projected to reduce this risk by 12.1%.
Conclusion: Recruitment of patients with PAD into an MDT intervention was feasible and timely, with strong retention and well-balanced baseline characteristics. While modelled estimates suggest a potential benefit from MDT recommendations, these findings are preliminary and based on a small interim cohort. Evaluation of clinical effectiveness within the larger ongoing randomised controlled trial is needed to evaluate the medium and long-term impacts of integrated vascular care.
期刊介绍:
Annals of Vascular Surgery, published eight times a year, invites original manuscripts reporting clinical and experimental work in vascular surgery for peer review. Articles may be submitted for the following sections of the journal:
Clinical Research (reports of clinical series, new drug or medical device trials)
Basic Science Research (new investigations, experimental work)
Case Reports (reports on a limited series of patients)
General Reviews (scholarly review of the existing literature on a relevant topic)
Developments in Endovascular and Endoscopic Surgery
Selected Techniques (technical maneuvers)
Historical Notes (interesting vignettes from the early days of vascular surgery)
Editorials/Correspondence